Literature DB >> 25063755

20 years of leptin: role of leptin in energy homeostasis in humans.

Michael Rosenbaum1, Rudolph L Leibel2.   

Abstract

The hyperphagia, low sympathetic nervous system tone, and decreased circulating concentrations of bioactive thyroid hormones that are common to states of congenital leptin deficiency and hypoleptinemia following and during weight loss suggest that the major physiological function of leptin is to signal states of negative energy balance and decreased energy stores. In weight-reduced humans, these phenotypes together with pronounced hypometabolism and increased parasympathetic nervous system tone create the optimal circumstance for weight regain. Based on the weight loss induced by leptin administration in states of leptin deficiency (obese) and observed similarity of phenotypes in states of congenital and dietary-induced states of hypoleptinemia (reduced obese), it has been suggested that exogenous leptin could potentially be useful in initiating, promoting, and sustaining weight reduction. However, the responses of human beings to exogenous leptin administration are dependent not only on extant energy stores but also on energy balance. Leptin administration to humans at usual weight has little, if any, effect on body weight while leptin administration during weight loss mitigates hunger, especially if given in supraphysiological doses during severe caloric restriction. Leptin repletion is most effective following weight loss by dietary restriction. In this state of weight stability but reduced energy stores, leptin at least partially reverses many of the metabolic, autonomic, neuroendocrine, and behavioral adaptations that favor weight regain. The major physiological function of leptin is to signal states of negative energy balance and decreased energy stores. Leptin, and pharmacotherapies affecting leptin signaling pathways, is likely to be most useful in sustaining weight loss.
© 2014 Society for Endocrinology.

Entities:  

Keywords:  energy; leptin; metabolism; obesity

Mesh:

Substances:

Year:  2014        PMID: 25063755      PMCID: PMC4454393          DOI: 10.1530/JOE-14-0358

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  109 in total

1.  Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.

Authors:  Jennifer H Lee; Jean L Chan; Epaminondas Sourlas; Vassilios Raptopoulos; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2006-04-24       Impact factor: 5.958

2.  Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects.

Authors:  Rochelle Goldsmith; Denis R Joanisse; Dympna Gallagher; Katherine Pavlovich; Elisabeth Shamoon; Rudolph L Leibel; Michael Rosenbaum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-04       Impact factor: 3.619

Review 3.  Clinical review 94: What's in a name? In search of leptin's physiologic role.

Authors:  J S Flier
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

4.  Secondary amenorrhea resulting from uncontrolled weight-reducing diets.

Authors:  A Lev-Ran
Journal:  Fertil Steril       Date:  1974-05       Impact factor: 7.329

5.  Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.

Authors:  Elizabeth Sienkiewicz; Faidon Magkos; Konstantinos N Aronis; Mary Brinkoetter; John P Chamberland; Sharon Chou; Kalliopi M Arampatzi; Chuanyun Gao; Anastasia Koniaris; Christos S Mantzoros
Journal:  Metabolism       Date:  2011-07-07       Impact factor: 8.694

6.  Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men.

Authors:  M S Westerterp-Plantenga; W H Saris; C J Hukshorn; L A Campfield
Journal:  Am J Clin Nutr       Date:  2001-10       Impact factor: 7.045

7.  Leptin reverses declines in satiation in weight-reduced obese humans.

Authors:  Harry R Kissileff; John C Thornton; Migdalia I Torres; Katherine Pavlovich; Laurel S Mayer; Vamsi Kalari; Rudolph L Leibel; Michael Rosenbaum
Journal:  Am J Clin Nutr       Date:  2012-01-11       Impact factor: 7.045

8.  Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men.

Authors:  M P G M Lejeune; C J Hukshorn; W H M Saris; M S Westerterp-Plantenga
Journal:  Int J Obes Relat Metab Disord       Date:  2003-12

9.  Leptin: a molecule integrating somatic energy stores, energy expenditure and fertility.

Authors:  M Rosenbaum; R L Leibel
Journal:  Trends Endocrinol Metab       Date:  1998-04       Impact factor: 12.015

10.  Hypothalamic control of food intake in rats and cats.

Authors:  B K ANAND; J R BROBECK
Journal:  Yale J Biol Med       Date:  1951-11
View more
  83 in total

1.  Effects of proanthocyanidin on oxidative stress biomarkers and adipokines in army cadets: a placebo-controlled, double-blind study.

Authors:  Mariana C Gonçalves; Magna C F Passos; Cyntia F de Oliveira; Julio B Daleprane; Josely C Koury
Journal:  Eur J Nutr       Date:  2015-12-24       Impact factor: 5.614

2.  Dysfunctional Eating Behaviour and Leptin in Middle-Aged Women: Role of Menopause and a History of Anorexia Nervosa.

Authors:  Suzana Stojiljkovic-Drobnjak; Susanne Fischer; Myrtha Arnold; Wolfgang Langhans; Ulrike Kuebler; Ulrike Ehlert
Journal:  Int J Behav Med       Date:  2021-03-15

3.  A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk.

Authors:  Johannes Hebebrand; Jens-Christian Holm; Euan Woodward; Jennifer Lyn Baker; Ellen Blaak; Dominique Durrer Schutz; Nathalie J Farpour-Lambert; Gema Frühbeck; Jason G C Halford; Lauren Lissner; Dragan Micic; Dana Mullerova; Gabriela Roman; Karin Schindler; Hermann Toplak; Tommy L S Visscher; Volkan Yumuk
Journal:  Obes Facts       Date:  2017-07-22       Impact factor: 3.942

Review 4.  Examining weight suppression as a transdiagnostic factor influencing illness trajectory in bulimic eating disorders.

Authors:  Pamela K Keel; Lindsay P Bodell; K Jean Forney; Jonathan Appelbaum; Diana Williams
Journal:  Physiol Behav       Date:  2019-05-30

5.  Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss.

Authors:  Russell T Turner; Michael Dube; Adam J Branscum; Carmen P Wong; Dawn A Olson; Xiaoying Zhong; Mercedes F Kweh; Iske V Larkin; Thomas J Wronski; Clifford J Rosen; Satya P Kalra; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2015-10-20       Impact factor: 4.286

6.  Quality of life improves in children and adolescents during a community-based overweight and obesity treatment.

Authors:  Pernille M Mollerup; Tenna R H Nielsen; Christine Bøjsøe; Julie T Kloppenborg; Jennifer L Baker; Jens-Christian Holm
Journal:  Qual Life Res       Date:  2017-02-17       Impact factor: 4.147

7.  Effects of birth weight and dietary fat on intake, body composition, and plasma thyroxine in neonatal lambs.

Authors:  Jose M Ramos-Nieves; Sarah L Giesy; Molly M McGuckin; Yves R Boisclair
Journal:  J Anim Sci       Date:  2020-12-01       Impact factor: 3.159

Review 8.  The role of leptin in regulating bone metabolism.

Authors:  Jagriti Upadhyay; Olivia M Farr; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-10-25       Impact factor: 8.694

Review 9.  Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence.

Authors:  Tim Hollstein; Paolo Piaggi
Journal:  Curr Obes Rep       Date:  2020-06

10.  Models of energy homeostasis in response to maintenance of reduced body weight.

Authors:  Michael Rosenbaum; Rudolph L Leibel
Journal:  Obesity (Silver Spring)       Date:  2016-08       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.